Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04300140
Title Efficacy and Safety Study of AVB-S6-500 in Patients With Clear Cell Renal Cell Carcinoma
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Aravive, Inc.

clear cell renal cell carcinoma


AVB-S6-500 + Cabozantinib


Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.